School of Criminology, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A1S6, Canada.
British Columbia Center for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
BMC Public Health. 2024 Feb 8;24(1):407. doi: 10.1186/s12889-024-17845-y.
In January 2023, British Columbia implemented a three-year exemption to Controlled Drugs and Substances Act, as granted by the federal government of Canada, to decriminalize the personal possession of small amounts of certain illegal drugs. This decriminalization policy, the first in Canada, was announced in response to the overdose emergency in British Columbia as a public health intervention that could help curb overdose deaths by reducing the impact of criminalization and increasing access to health and social services through stigma reduction.
The current multi-method study examines people who use drugs' awareness and knowledge of British Columbia's decriminalization model through cross-sectional quantitative surveys and qualitative interviews among people who use drugs from September-November 2022, immediately prior to the implementation of decriminalization.
Quantitative findings show that two-thirds (63%) of people who use drugs were aware of the policy, but substantial knowledge gaps existed about the legal protections afforded (threshold amount, substances included, drug trafficking, confiscation). The qualitative findings suggest that people who use drugs misunderstood the details of the provincial decriminalization model and often conflated it with regulation. Results suggest that information sharing about decriminalization were minimal pre-implementation, highlighting areas for knowledge dissemination about people who use drugs' rights under this policy.
Given that decriminalization in British Columbia is a new and landmark reform, and that the success of decriminalization and its benefits may be undermined by poor awareness and knowledge of it, efforts to share information, increase understanding, and empower the community, may be required to promote its implementation and benefits for the community.
2023 年 1 月,不列颠哥伦比亚省根据加拿大联邦政府的授权,实施了为期三年的《受控药物和物质法》豁免,将个人持有少量某些非法药物合法化。这项合法化政策是加拿大的首例,旨在应对不列颠哥伦比亚省的药物过量紧急情况,作为一项公共卫生干预措施,通过减少刑事定罪的影响和通过减少污名化增加获得健康和社会服务的机会,有助于遏制药物过量死亡。
本多方法研究通过 2022 年 9 月至 11 月期间在不列颠哥伦比亚省实施药物合法化之前进行的横断面定量调查和吸毒者的定性访谈,研究了吸毒者对该省合法化模式的认识和了解。
定量研究结果表明,三分之二(63%)的吸毒者了解该政策,但对所提供的法律保护(门槛金额、包括的物质、毒品贩卖、没收)存在明显的知识差距。定性研究结果表明,吸毒者对省级合法化模式的细节存在误解,并且经常将其与监管混淆。结果表明,实施前关于合法化的信息共享很少,突显了在该政策下向吸毒者传播有关其权利的知识的领域。
鉴于不列颠哥伦比亚省的合法化是一项新的、具有里程碑意义的改革,而且对该政策缺乏认识和了解可能会破坏其成功和利益,因此可能需要努力分享信息、提高理解能力并赋予社区权力,以促进其实施和为社区带来的利益。